首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1746564

日本組織診斷市場報告（按產品類型、技術、疾病、最終用戶和地區）2025-2033

Japan Tissue Diagnostics Market Report by Product Type, Technology, Disease, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本組織診斷市場規模達2.436億美元。展望未來， IMARC Group預計到2033年，市場規模將達到4.404億美元，2025-2033年期間的複合年成長率（CAGR）為6.3%。數位病理學、新一代定序（NGS）和先進影像技術等技術的不斷進步，提高了組織診斷的準確性和效率，推動市場的發展。

組織診斷是醫學領域的一個重要領域，它透過顯微鏡檢查和分析組織樣本來診斷疾病並探討其潛在病因。它在識別各種疾病（包括癌症、感染、發炎性疾病和自體免疫疾病）方面發揮著重要作用。這個過程通常始於透過活體組織切片或手術等程序採集組織標本。這些樣本隨後經過處理，包埋於石蠟中，切成薄片，並用特定染料染色以增強顯微鏡下的可視性。經驗豐富的病理學家和組織技師會檢查這些染色的組織切片，以識別異常的細胞結構、模式和標記。組織診斷幫助臨床醫生就患者的治療方案做出明智的決定，包括選擇療法、手術或藥物。免疫組織化學和分子檢測等技術的進步進一步提高了組織診斷的精確度和特異性，從而實現了個人化醫療。該領域不斷發展，為疾病的早期檢測、預後預測和個人化患者護理做出了重要貢獻。

日本組織診斷市場趨勢：

日本組織診斷市場正在經歷大幅成長，主要由以下幾個關鍵因素所驅動。首先，癌症發生率的上升需要先進的診斷技術，從而推動了組織診斷需求的激增。此外，老年人口的快速成長也進一步推動了這項需求，他們更容易罹患慢性病。此外，分子診斷領域的技術進步徹底改變了組織檢測，使其更有效率和準確。此外，患者和醫療保健提供者對個人化醫療的認知也顯著提高。這導致人們更加重視早期疾病檢測和個人化治療，凸顯了組織診斷的關鍵作用。此外，政府和私人機構為癌症診斷研究提供資金和資助的舉措無疑刺激了市場成長。此外，生物標記識別技術的不斷發展促進了新型診斷工具的開發，預計將推動日本組織診斷市場的發展。

日本組織診斷市場細分：-

產品類型洞察：

儀器
耗材

技術洞察：

免疫組織化學
原位雜合技術
數位病理學和工作流程管理
特殊染色

疾病見解：

乳癌
胃癌
淋巴瘤
攝護腺癌
非小細胞肺癌
其他

最終用戶洞察：

醫院
研究實驗室
製藥公司
合約研究組織
其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭指標和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本組織診斷市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本組織診斷市場有何影響？
根據產品類型，日本組織診斷市場是如何分類的？
日本組織診斷市場依技術分類的分佈如何？
日本組織診斷市場依疾病的分類是怎樣的？
根據最終用戶，日本組織診斷市場的分佈如何？
日本組織診斷市場的價值鏈分為哪些階段？
日本組織診斷的主要促進因素和挑戰是什麼？
日本組織診斷市場的結構是怎麼樣的？主要參與者是誰？
日本組織診斷市場的競爭程度如何？

本報告回答的關鍵問題：

日本組織診斷市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本組織診斷市場有何影響？
根據產品類型，日本組織診斷市場是如何分類的？
日本組織診斷市場依技術分類的分佈如何？
日本組織診斷市場依疾病的分類是怎樣的？
根據最終用戶，日本組織診斷市場的分佈如何？
日本組織診斷市場的價值鏈分為哪些階段？
日本組織診斷的主要促進因素和挑戰是什麼？
日本組織診斷市場的結構是怎麼樣的？主要參與者是誰？
日本組織診斷市場的競爭程度如何？

Japan tissue diagnostics market size reached USD 243.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 440.4 Million by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. The rising advances in technology, such as digital pathology, next-generation sequencing (NGS), and advanced imaging techniques, which have improved the accuracy and efficiency of tissue diagnostics, are driving the market.

Tissue diagnostics is a crucial field in medicine that involves the microscopic examination and analysis of tissue samples to diagnose diseases and provide insights into their underlying causes. It plays a fundamental role in identifying various medical conditions, including cancer, infections, inflammatory disorders, and autoimmune diseases. The process typically begins with the collection of tissue specimens obtained through procedures like biopsies or surgeries. These samples are then processed, embedded in paraffin wax, sliced into thin sections, and stained with specific dyes to enhance visibility under a microscope. Skilled pathologists and histotechnologists examine these stained tissue sections to identify abnormal cellular structures, patterns, and markers. Tissue diagnostics help clinicians make informed decisions about patient treatment plans, including the choice of therapies, surgeries, or medications. Advances in technology, such as immunohistochemistry and molecular testing, have further improved the precision and specificity of tissue diagnostics, enabling personalized medicine approaches. This field continues to evolve, contributing significantly to early disease detection, prognosis prediction, and tailored patient care.

Japan Tissue Diagnostics Market Trends:

The tissue diagnostics market in Japan is experiencing substantial growth, primarily driven by several key factors. Firstly, the increasing prevalence of cancer necessitates advanced diagnostic techniques, fostering a surge in demand for tissue diagnostics. Additionally, the burgeoning geriatric population, who are more susceptible to chronic diseases, further propels this demand. Furthermore, technological advancements in the realm of molecular diagnostics have revolutionized tissue-based testing, rendering it more efficient and accurate. Also, there has been a significant rise in the awareness of personalized medicine among patients and healthcare providers alike. This has led to an increased emphasis on early disease detection and treatment customization, emphasizing the critical role of tissue diagnostics. Moreover, initiatives by government and private organizations to provide funding and grants for research in cancer diagnostics undeniably spur market growth. Apart from this, the continuous evolution in biomarker identification that is bolstering the development of new diagnostic tools is expected to drive the tissue diagnostics market in Japan.

Japan Tissue Diagnostics Market Segmentation: -

Product Type Insights:

Instruments
Consumables

Technology Insights:

Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow Management
Special Staining

Disease Insights:

Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-Small Cell Lung Cancer
Others

End User Insights:

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan tissue diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan tissue diagnostics market?
What is the breakup of the Japan tissue diagnostics market on the basis of product type?
What is the breakup of the Japan tissue diagnostics market on the basis of technology?
What is the breakup of the Japan tissue diagnostics market on the basis of disease?
What is the breakup of the Japan tissue diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan tissue diagnostics market?
What are the key driving factors and challenges in the Japan tissue diagnostics?
What is the structure of the Japan tissue diagnostics market and who are the key players?
What is the degree of competition in the Japan tissue diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Tissue Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Tissue Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Tissue Diagnostics Market - Breakup by Product Type

6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Consumables
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Tissue Diagnostics Market - Breakup by Technology

7.1 Immunohistochemistry
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 In Situ Hybridization
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Digital Pathology and Workflow Management
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Special Staining
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)

8 Japan Tissue Diagnostics Market - Breakup by Disease

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Gastric Cancer
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Lymphoma
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Prostate Cancer
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Non-Small Cell Lung Cancer
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 8.6.2 Market Forecast (2025-2033)

9 Japan Tissue Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Pharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Contract Research Organizations
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2019-2024)
- 9.5.2 Market Forecast (2025-2033)

10 Japan Tissue Diagnostics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Tissue Diagnostics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis